Asialo GM1 as a Cell-Surface Marker in Acute Lymphoblastic Leukemia

To the Editor: The study of Nakahara et al. in the issue of March 20 proposes that the glycolipid asialo GM 1 is a unique cell-surface marker for acute lymphoblastic leukemia and distinguishes these patients from patients with other hematologic cancers. Using a rabbit heteroantiserum to this glycoli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1981-01, Vol.304 (5), p.300-301
Hauptverfasser: Schwarting, G A, Parkinson, D R, Munson, D, Zielinski, C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 301
container_issue 5
container_start_page 300
container_title The New England journal of medicine
container_volume 304
creator Schwarting, G A
Parkinson, D R
Munson, D
Zielinski, C
description To the Editor: The study of Nakahara et al. in the issue of March 20 proposes that the glycolipid asialo GM 1 is a unique cell-surface marker for acute lymphoblastic leukemia and distinguishes these patients from patients with other hematologic cancers. Using a rabbit heteroantiserum to this glycolipid, they showed that lymphocytes from all 16 patients were positive according to immunofluorescence analysis, whereas lymphocytes from 44 patients with other neoplasias and disorders were negative. We have attempted to repeat these studies in our laboratory but have been unable to corroborate these findings. We examined the blast cells of six patients . . . No extract is available for articles shorter than 400 words.
doi_str_mv 10.1056/NEJM198101293040515
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_75530212</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75530212</sourcerecordid><originalsourceid>FETCH-LOGICAL-m242t-b6fca166af92c0c2ad7b5c42e10c27bdd4782ca62c3a1175dc0b15f0acc662252</originalsourceid><addsrcrecordid>eNptkDtPw0AQhE8IFELgFyCkq2iQYfdejsvICi85UAC1tT6fhRNfHHx2kX-PUVKyzWg1n1Y7w9g1wj2CNg9vy9cVJnMEFIkEBRr1CZuiljJSCswpmwKIeaTiRJ6zixDWMA6qZMImMYCUiZyydBFqalr-tEJOgRNPXdNEH0NXkXV8Rd3Gdbze8oUdesezvd99t0VDoa8tz9ywcb6mS3ZWURPc1VFn7Otx-Zk-R9n700u6yCIvlOijwlSW0BiqEmHBCirjQlslHI5LXJSliufCkhFWEmKsSwsF6grIWmOE0GLGbg93d137M7jQ574OdvyXtq4dQh5rLUGgGMGbIzgU3pX5rqs9dfv8mHr07w6-9yHfurXPEfK_SvN_KhW_KYtkkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75530212</pqid></control><display><type>article</type><title>Asialo GM1 as a Cell-Surface Marker in Acute Lymphoblastic Leukemia</title><source>MEDLINE</source><creator>Schwarting, G A ; Parkinson, D R ; Munson, D ; Zielinski, C</creator><creatorcontrib>Schwarting, G A ; Parkinson, D R ; Munson, D ; Zielinski, C</creatorcontrib><description>To the Editor: The study of Nakahara et al. in the issue of March 20 proposes that the glycolipid asialo GM 1 is a unique cell-surface marker for acute lymphoblastic leukemia and distinguishes these patients from patients with other hematologic cancers. Using a rabbit heteroantiserum to this glycolipid, they showed that lymphocytes from all 16 patients were positive according to immunofluorescence analysis, whereas lymphocytes from 44 patients with other neoplasias and disorders were negative. We have attempted to repeat these studies in our laboratory but have been unable to corroborate these findings. We examined the blast cells of six patients . . . No extract is available for articles shorter than 400 words.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM198101293040515</identifier><identifier>PMID: 7003393</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Adolescent ; Adult ; Cell Membrane - immunology ; Child ; Child, Preschool ; Chromatography, Liquid ; Fluorescent Antibody Technique ; G(M1) Ganglioside - blood ; Gangliosides - blood ; Humans ; Infant ; Leukemia, Lymphoid - blood ; Leukemia, Lymphoid - diagnosis</subject><ispartof>The New England journal of medicine, 1981-01, Vol.304 (5), p.300-301</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7003393$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwarting, G A</creatorcontrib><creatorcontrib>Parkinson, D R</creatorcontrib><creatorcontrib>Munson, D</creatorcontrib><creatorcontrib>Zielinski, C</creatorcontrib><title>Asialo GM1 as a Cell-Surface Marker in Acute Lymphoblastic Leukemia</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor: The study of Nakahara et al. in the issue of March 20 proposes that the glycolipid asialo GM 1 is a unique cell-surface marker for acute lymphoblastic leukemia and distinguishes these patients from patients with other hematologic cancers. Using a rabbit heteroantiserum to this glycolipid, they showed that lymphocytes from all 16 patients were positive according to immunofluorescence analysis, whereas lymphocytes from 44 patients with other neoplasias and disorders were negative. We have attempted to repeat these studies in our laboratory but have been unable to corroborate these findings. We examined the blast cells of six patients . . . No extract is available for articles shorter than 400 words.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Cell Membrane - immunology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chromatography, Liquid</subject><subject>Fluorescent Antibody Technique</subject><subject>G(M1) Ganglioside - blood</subject><subject>Gangliosides - blood</subject><subject>Humans</subject><subject>Infant</subject><subject>Leukemia, Lymphoid - blood</subject><subject>Leukemia, Lymphoid - diagnosis</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>false</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkDtPw0AQhE8IFELgFyCkq2iQYfdejsvICi85UAC1tT6fhRNfHHx2kX-PUVKyzWg1n1Y7w9g1wj2CNg9vy9cVJnMEFIkEBRr1CZuiljJSCswpmwKIeaTiRJ6zixDWMA6qZMImMYCUiZyydBFqalr-tEJOgRNPXdNEH0NXkXV8Rd3Gdbze8oUdesezvd99t0VDoa8tz9ywcb6mS3ZWURPc1VFn7Otx-Zk-R9n700u6yCIvlOijwlSW0BiqEmHBCirjQlslHI5LXJSliufCkhFWEmKsSwsF6grIWmOE0GLGbg93d137M7jQ574OdvyXtq4dQh5rLUGgGMGbIzgU3pX5rqs9dfv8mHr07w6-9yHfurXPEfK_SvN_KhW_KYtkkA</recordid><startdate>19810129</startdate><enddate>19810129</enddate><creator>Schwarting, G A</creator><creator>Parkinson, D R</creator><creator>Munson, D</creator><creator>Zielinski, C</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19810129</creationdate><title>Asialo GM1 as a Cell-Surface Marker in Acute Lymphoblastic Leukemia</title><author>Schwarting, G A ; Parkinson, D R ; Munson, D ; Zielinski, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-m242t-b6fca166af92c0c2ad7b5c42e10c27bdd4782ca62c3a1175dc0b15f0acc662252</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Cell Membrane - immunology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chromatography, Liquid</topic><topic>Fluorescent Antibody Technique</topic><topic>G(M1) Ganglioside - blood</topic><topic>Gangliosides - blood</topic><topic>Humans</topic><topic>Infant</topic><topic>Leukemia, Lymphoid - blood</topic><topic>Leukemia, Lymphoid - diagnosis</topic><toplevel>peer_reviewed</toplevel><creatorcontrib>Schwarting, G A</creatorcontrib><creatorcontrib>Parkinson, D R</creatorcontrib><creatorcontrib>Munson, D</creatorcontrib><creatorcontrib>Zielinski, C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>no_fulltext</fulltext></delivery><addata><au>Schwarting, G A</au><au>Parkinson, D R</au><au>Munson, D</au><au>Zielinski, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Asialo GM1 as a Cell-Surface Marker in Acute Lymphoblastic Leukemia</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1981-01-29</date><risdate>1981</risdate><volume>304</volume><issue>5</issue><spage>300</spage><epage>301</epage><pages>300-301</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor: The study of Nakahara et al. in the issue of March 20 proposes that the glycolipid asialo GM 1 is a unique cell-surface marker for acute lymphoblastic leukemia and distinguishes these patients from patients with other hematologic cancers. Using a rabbit heteroantiserum to this glycolipid, they showed that lymphocytes from all 16 patients were positive according to immunofluorescence analysis, whereas lymphocytes from 44 patients with other neoplasias and disorders were negative. We have attempted to repeat these studies in our laboratory but have been unable to corroborate these findings. We examined the blast cells of six patients . . . No extract is available for articles shorter than 400 words.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>7003393</pmid><doi>10.1056/NEJM198101293040515</doi><tpages>2</tpages></addata></record>
fulltext no_fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1981-01, Vol.304 (5), p.300-301
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_75530212
source MEDLINE
subjects Adolescent
Adult
Cell Membrane - immunology
Child
Child, Preschool
Chromatography, Liquid
Fluorescent Antibody Technique
G(M1) Ganglioside - blood
Gangliosides - blood
Humans
Infant
Leukemia, Lymphoid - blood
Leukemia, Lymphoid - diagnosis
title Asialo GM1 as a Cell-Surface Marker in Acute Lymphoblastic Leukemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T08%3A05%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Asialo%20GM1%20as%20a%20Cell-Surface%20Marker%20in%20Acute%20Lymphoblastic%20Leukemia&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Schwarting,%20G%20A&rft.date=1981-01-29&rft.volume=304&rft.issue=5&rft.spage=300&rft.epage=301&rft.pages=300-301&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM198101293040515&rft_dat=%3Cproquest_pubme%3E75530212%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75530212&rft_id=info:pmid/7003393&rfr_iscdi=true